
Chrysalis Investments - Update from QuotedData
5 December 2025
The road ahead
Chrysalis Investments (CHRY) is now seven years old, with a more mature portfolio. Since our last update, strong performance from Starling and signs of recovery at wefox have boosted NAV. Recent asset sales have provided enough liquidity for CHRY to meet its capital allocation commitments, and Klarna's IPO increases the chance of further realisations.
Over 16% of CHRY's shares have been bought back, narrowing the discount, though there is still room for improvement. Some investors have asked for an exit near asset value, while others, encouraged by CHRY's NAV growth, are interested in new investments. After consulting shareholders, the board is planning the next steps.
Full Research:
https://quoteddata.com/research/chrysalis-investments-the-road-ahead-qd/
This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.
NB: Marten & Co was paid to produce this note Chrysalis Investments Limited, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.
QUOTEDDATA
50 Gresham Street | London EC2V 7AY
Tel: +44 (0) 20 3691 9430
www.quoteddata.com | research@quoteddata.com | www.martenandco.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.